Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers

被引：20
|
作者：
Özdemir, V [1 ]
Tyndale, RF
Reed, K
Herrmann, N
Sellers, EM
Kalow, W
Naranjo, CA
机构：
[1] Univ Toronto, Dept Pharmacol, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Psychopharmacol Res Program, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Womens Coll Hosp, Psychopharmacol & Dependence Res Unit, Toronto, ON M4N 3M5, Canada
[4] Univ Toronto, Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON M4N 3M5, Canada
[5] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M4N 3M5, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON M4N 3M5, Canada
[7] Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1999年 / 19卷 / 05期
关键词：
D O I：
10.1097/00004714-199910000-00014
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：472 / 475
页数：4
相关论文
共 50 条
  • [1] Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers
    Begré, S
    von Bardeleben, U
    Ladewig, D
    Jaquet-Rochat, S
    Cosendai-Savary, L
    Golay, KP
    Kosel, M
    Baumann, P
    Eap, CB
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 211 - 215
  • [2] Effects of number of CYP2D6 mutated alleles on steady-state plasma concentration of paroxetine
    Sawamura, K
    Suzuki, Y
    Kawashima, Y
    Sato, S
    Shimoda, K
    Someya, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 181 - 182
  • [3] Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline
    Davies, Benjamin J.
    Herbert, Megan K.
    Coller, Janet K.
    Somogyi, Andrew A.
    Milne, Robert W.
    Sallustio, Benedetta C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (03) : 347 - 354
  • [4] Impact of CYP2D6 Genotype on Paroxetine Serum Concentration
    Hole, Kristine
    Haslemo, Tore
    Molden, Espen
    THERAPEUTIC DRUG MONITORING, 2023, 45 (05) : 683 - 688
  • [5] Dose-Dependent Effect of the CYP2D6 Genotype on the Steady-state Fluvoxamine Concentration
    Watanabe, Junzo
    Suzuki, Yutaro
    Fukui, Naoki
    Sugai, Takuro
    Ono, Shin
    Inoue, Yoshimasa
    Someya, Toshiyuki
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 705 - 708
  • [6] Impact of CYP2D6 genotypes on the steady-state plasma concentrations of paroxetine in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Okawa, M
    Shimoda, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 178 - 178
  • [7] CHLORPHENIRAMINE PLASMA ANTAGONIST ACTIVITY IN POOR AND EXTENSIVE METABOLIZERS OF CYP2D6
    YASUDA, SU
    BARBEY, JT
    HEWETT, J
    WOOSLEY, RL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 170 - 170
  • [8] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Okawa, M
    Shimoda, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 181 - 181
  • [9] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Yokono, A
    Okawa, M
    Shimoda, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S223 - S223
  • [10] Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 extensive and poor metabolisers
    Sallustio, Benedetta C.
    Davies, Benjamin J.
    Herbert, Megan K.
    Coller, Janet K.
    Somogyi, Andrew A.
    Milne, Robert W.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 478 - 478
12345